New Staging System: How Does It Affect Our Practice?

摘要: The anatomic extent of disease, as described by the TNM classification, remains most powerful prognostic indicator for lung cancer. It is used daily specialists in all branches cancer care and research. Any new edition classification therefore an important event thoracic oncology community one greeted with mixed feelings. changes introduced seventh were first 13 years arguably profound since data-driven revision more than 40 earlier. Inevitably there will be concerns that any change T, N, or M descriptors resultant stage groupings have implications previous treatment pathways. In this article, to are described, their possible impacts on clinical research discussed.